Zvi Vaknin

Prof. Zvi Vaknin

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Medicine
Verified
Journal Article
Open access
PDF file
AMAnca Mihailovici
Anca Mihailovici
MRMisgav Rottenstreich
Misgav Rottenstreich
SKSvetlana Kovel
Svetlana Kovel
IWIlan Wassermann
Ilan Wassermann
NSNoam Smorgick
Noam Smorgick
ZVZvi Vaknin
Zvi Vaknin
Endometriosis-associated malignant transformation in abdominal surgical scar (EAMTAS) is a very rare and aggressive phenomenon. Our current article aims to provide a clinical overview, focusing on risk factors affecting survival. We performed a Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant systematic review based on prior reviews and case reports regarding the phenomenon published as abstracts in English, from January 1980 to November 2016. Overall, we identified 47 cases, and we included another case from our institution. We further contacted previous investigators to receive updated follow-up regarding their patients. We analyzed the data, focusing on risk factors that might affect overall survival. All the patients reported in the literature had a uterine surgery, mainly caesarean section. The median time-lag from first surgery to the diagnosis of cancer was about 19 years. Clear-cell carcinoma (CCC) was the most prevalent histology (67%), followed by endometrioid adenocarcinoma (15%). Most of the patients were treated by extensive surgery and chemotherapy and/or radiation. Overall 5 years survival was about 40%. Median overall survival was 42 months (95% confidence interval of [18.7, 65.3]). Although our review is currently the largest in the literature, we cannot draw any statistical significant results due to the limited number of patients reported. According to univariate Cox-regression models, a tendency toward worse prognosis was shown for 3-year disease-free survival clear cell histologic-type (P = .169), and tumor diameter ≥8 cm in nonclear-cell histology, 18 months postdiagnosis (P = .06). EAMTAS is a rare and aggressive disease. It is mostly related to cesarean section scars and is diagnosed many years postsurgery. Clear-cell histology tends to endure from the worse prognosis. The treatment is mainly extensive surgery and adjuvant chemotherapy and/or radiotherapy.

2 November 2020 in Israel Journal of Health Policy Research
Verified
Journal Article
Open access
PDF file
ASAdi Sofer
Adi Sofer
RMRacheli Magnezi
Racheli Magnezi
RERam Eitan
Ram Eitan
OROded Raban
Oded Raban
OTOrna Tal
Orna Tal
ZVZvi Vaknin
Zvi Vaknin
Background: This retrospective study compared perioperative measures, costs, quality of life and survival after open vs. robotic surgery, among obese women diagnosed with low-grade endometrial cancer. Methods: Obese women (body mass index (BMI) ≥ 30) who underwent open or robotic surgery for endometrial cancer, in one of two tertiary medical centers in the center of Israel, 2013–2016, postoperative grade 1–2, were included. Costs per patient, including 30-days post-surgery were calculated. Quality of life was evaluated by Physical and Mental Components of the SF-36 and a recovery from surgery questionnaire. Overall survival outcomes were obtained from patients’ files. Surgical outcomes, including operating and anesthesia times, length of hospital stay, and intraoperative and postoperative complications according to the Clavien-Dindo classification scale were reviewed. Results: In all, 138 women with BMI ≥30 underwent open (n = 61) or robotic surgery (n = 77) during the study period. The groups had similar BMI, comorbidities, demographics and tumor characteristics. Robotic surgery was associated with shorter hospital stays (mean 1.7 vs. 4.8 days; P < .0001) and fewer postoperative complications (Clavien-Dindo > 2, 5.2% vs. 19.7%; P = .0008), but longer operating theater time (3.8 vs. 2.8 h; P < .001). Costs are equivalent when at least 350 robotic surgeries are performed annually, not including the initial system costs. Quality of life measures were better after robotic surgery. SF-36 showed better measures for robotic surgery (Physical 56 vs. 39 and Mental 73 vs. 56; P < .01). After robotic surgery, patients tended to recover quicker when compared to open surgery, as they returned to normal activities earlier, with less need for family and governmental assistance (mean recovery time, 23 vs. 70 days; P < 0.006 and mean change in preoperative total functioning score, − 1.5 vs. -3.9: P < 0.05, respectively). Overall, 5-year survival was 89.8% for the open surgery group vs. 94% for the robotic surgery group (log rank, P = 0.330). Conclusions: Obese women with low-grade endometrial cancer had better quality of life after robotic vs. open surgery. They also had shorter hospital stays and fewer postoperative complications. Centers with high volumes of robotic surgery can achieve similar costs when comparing both methods. These results were achieved without jeopardizing survival. Our results further emphasize the need for the Israeli healthcare system to include specific reimbursement for robotic procedures in the population we studied.

1 August 2016 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
MRMisgav Rottenstreich
Misgav Rottenstreich
NSNoam Smorgick
Noam Smorgick
MPMoty Pansky
Moty Pansky
ZVZvi Vaknin
Zvi Vaknin

1 July 2025 in Menopause
Verified
Journal Article
Closed access
YBYael Tal Bliman
Yael Tal Bliman
TYTal Rafaeli Yehudai
Tal Rafaeli Yehudai
YSYair Shiber
Yair Shiber
MMMatan Mor
Matan Mor
ZVZvi Vaknin
Zvi Vaknin
Objective: Pyometra is a rare but serious condition, particularly in postmenopausal women. While commonly linked to postpartum or post-surgical complications, spontaneous pyometra may also be associated with underlying gynecologic malignancies. We aim to examine the association between postmenopausal spontaneous pyometra (PMSP) and gynecologic cancers. Methods: A retrospective review of consecutive women admitted with pyometra between 2007 and 2023, at a university-affiliated tertiary medical center. Demographic and clinical data were reviewed. Women with pyometra and gynecologic cancer were compared with those without. Results: Of 231 admissions for pyometra, 47 women with PMSP were identified. The cohort was divided into a benign group (n=35, 74.4%) and malignancy group (n=12, 25.6%). Endometrial carcinoma (n=8, 67%) was the predominant malignancy, followed by cervical cancer (n=4, 33%). Although age, age at menopause, and parity showed no significant statistical differences between the groups, a higher body mass index was significantly associated with endometrial malignancy ( P = 0.014). Postmenopausal bleeding as an accompanying symptom to pyometra was also more common in the malignancy group ( P =0.001). The prevalence of PMSP was 1.1% for endometrial cancer and 2.2% for cervical cancer. Conclusions: PMSP is significantly associated with gynecologic malignancies, particularly endometrial and cervical cancers. Notably, women with endometrial malignancy had a higher BMI and were more likely to present with accompanying postmenopausal bleeding. These findings suggest that in postmenopausal women presenting with spontaneous pyometra, clinicians should maintain a high index of suspicion for malignancy. Early identification and appropriate management are crucial to improving patient outcomes.

28 December 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
YSYair Shiber
Yair Shiber
RMRon Maymon
Ron Maymon
MGMaayan Gal-Kochav
Maayan Gal-Kochav
NKNadav Kugler
Nadav Kugler
MPMarina Pekar-Zlotin
Marina Pekar-Zlotin
ZVZvi Vaknin
Zvi Vaknin

29 September 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
MMMatan Mor
Matan Mor
ALAmit Levi
Amit Levi
TRTal Rafaeli-Yehudai
Tal Rafaeli-Yehudai
JEJodi Ezratty
Jodi Ezratty
YSYair Shiber
Yair Shiber
ZVZvi Vaknin
Zvi Vaknin